ArticleBMJ global health2025
Operationalising an integrated mortality transition framework for programmatic priority setting across maternal and newborn health.
Article in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Maternal Mortality Among Black Women in Brazil: A Retrospective Cohort Study.International journal of environmental research and public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Data-driven decision making will be instrumental in reducing maternal mortality, newborn mortality, and stillbirth levels in the coming years as the Sustainable Development Goal targets draw near in 2030. Tailoring evidence to be context-specific is crucial to target relevant questions, priorities, and needs. In doing so, there remains value in grounding local data in the broader global health data landscape. Here, we introduce one resource - an interactive benchmarking tool- that presents local insights contextualized in a maturity model based on evidence from over 150 countries. This tool positions a country in one of five mortality phases, compares its performance across maternal/newborn health program areas to peers in its phase, and facilitates connections to lessons from high-performing Exemplar countries that have achieved success on relevant indicators. It offers an opportunity to set evidence-based priorities, helping to identify indicators and subnational regions that may be important to target moving forward to accelerate progress. In select countries, the benchmarking approach has been piloted to inform maternal and newborn health evaluations and planning processes. This approach is adaptable to local contexts and use-cases, while in parallel fostering a shared way of thinking around maternal and newborn health strategic planning. In a global health financing environment that is increasingly constrained, such a tool to support data-driven priority setting is a timely resource.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.